PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Alnylam Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
PRICE T ROWE ASSOCIATES INC | 4,074,144 3.300% |
-2,461,224 (-37.66%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
PRICE T ROWE ASSOCIATES INC | 6,535,368 5.400% |
2,859,543 (+77.79%) |
Filing |